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RESEARCH ARTICLE

Basal Signalling Through Death Receptor 5 and Caspase
3 Activates p38 Kinase to Regulate Serum Response
Factor (SRF)-Mediated MyoD Transcription
Jason A. Ross, Brianna Barrett, Victoria Bensimon, Girish Shukla and Crystal M. Weyman
We have previously reported that stable expression of a dominant negative Death Receptor 5 (dnDR5)
in skeletal myoblasts results in decreased basal caspase activity and decreased mRNA and protein
expression of the muscle regulatory transcription factor MyoD in growth medium (GM), resulting in

inhibited differentation when myoblasts are then cultured in differentiation media (DM). Further, this
decreased level of MyoD mRNA was not a consequence of altered message stability, but rather correlated
with decreased acetylation of histones in the distal regulatory region (DRR) of the MyoD extended
promoter known to control MyoD transcription. As serum response factor (SRF) is the transcription factor
known to be responsible for basal MyoD expression in GM, we compared the level of SRF binding to the
non-canonical serum response element (SRE) within the DRR in parental and dnDR5 expressing myoblasts.
Herein, we report that stable expression of dnDR5 resulted in decreased levels of serum response f
 actor
(SRF) binding to the CArG box in the SRE of the DRR. Total SRF expression levels were not affected, but
phosphorylation indicative of SRF activation was impaired. This decreased SRF phosphorylation correlated
with decreased phosphorylation-induced activation of p38 kinase. Moreover, the aforementioned signaling
events affected by expression of dnDR5 could be appropriately recapitulated using either a pharmacological
inhibitor of caspase 3 or p38 kinase. Thus, our results have established a signaling pathway from DR5
through caspases to p38 kinase activation, to SRF activation and the basal expression of MyoD.
Keywords: DR5; caspase 3; p38 kinase; SRF; MyoD

Introduction
The coordinate regulation of differentiation and apoptosis
is essential for proper development and tissue homeostasis. This synchronous control serves two distinct functions.
Firstly, in a few cell types, synchronous control of the differentiation and apoptotic processes is necessary because
functional differentiation requires certain morphological events associated with the apoptotic phenotype [1].
Secondly, in many cell types, the signaling pathways controlling differentiation and apoptosis are intertwined to
assure that either harmful cells or those generated in excess
are removed in an efficient manner that does not elicit an
immune response [2, 3]. The formation of skeletal muscle
utilizes this latter scenario that necessarily results in the distinct biological endpoints of either differentiation or apoptosis [4–7]. While the removal of excess cells is critical during
development, it is potentially detrimental to regeneration or
cell therapy. If blocking apoptosis while allowing differentiation is to be considered as a potential approach to increasing
the efficacy of regeneration or cell therapy, then a thorough
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understanding of how these processes are coordinately regulated is imperative [8, 9].
To this end, we have previosuly reported that the classically pro-apoptotic death receptor 5 (DR5)/FADD/caspase
8 pathway, in cooperation with increased levels of the proapoptotic Bcl2 family member PUMA, plays a role in the
efficient apoptosis associated with skeletal myoblast differentiation [10–12]. Specifically, when myoblasts expressing a dominant negative DR5 (dnDR5) are switched from
growth media (GM) to differentiation media (DM), caspase
activation, Bid cleavage, and the ensuing apoptosis are
severely impaired relative to parental myoblasts. However,
unlike the PUMA pathway, the DR5/FADD/caspase 8
pathway is also critical to skeletal myoblast differentiation.
The effect of the DR5/FADD/caspase pathway on differentiation is exerted in GM and results in decreased levels of MyoD mRNA and protein [13]. Thus, we designed
experiments to delineate the signalling pathway blocked
by dnDR5, and therefore engaged by DR5, that is responsible for maintaining MyoD mRNA, and thus protein,
levels. Herein, we present data to indicate that basal signalling through DR5 and caspase 3 activates p38 kinase
to regulate serum response factor (SRF)-mediated MyoD
transcription.
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Methods

Cells and cell culture

The growth 23A2 myoblasts and 23A2 myoblasts expressing dnDR5 have been reported previously [10]. The
Z-DEVD-fmk caspase inhibitor (20 µM final treatment
concentration; Calbiochem) and SB 203580 (3 µM treatment concentration; Sigma) were each dissolved in DMSO.
Appropriate volumes of DMSO or methanol alone were
added to control cultures and did not exceed 0.15% v/v.
Chromatin immunoprecipitation

ChIP was performed following the protocol provided in
the EZ-ChIPTM kit (Millipore/Upstate) and as described in
[13]. Cells were plated on 150 mm plates. The next day,
cells were fixed in 0.5% formaldehyde for 10 minutes at
room temperature. Formaldehyde was inactivated by the
addition of .125 M glycine to the cells for 5 minutes at
room temperature. Cells were then washed with ice cold
PBS containing 5 mM Na Butyrate and 0.5 mM PMSF and
pelleted by centrifugation at 1500 rpm for 5 minutes and
then resuspended in 5 ml cold Cell Lysis Buffer (CLB: 60
mM KCl, 15 mM NaCl, 5 mM MgCl, 10 mM Tris pH 7.4,
300 mM sucrose, 0.1 mM EGTA, 0.1% NP-40, 5 mM Na
Butyrate, 0.5 mM PMSF). Cells were sonicated once for
10 sec to ensure lysis of the plasma membrane. Isolated
nuclei were washed once in 30 ml of CLB and once in 1 ml
of cold Nuclei Digestion Buffer (Cell Lysis Buffer without NP-40 and PMSF). For MNase digestion, intact nuclei
were resuspended in 125 μl of Nuclei Lysis Buffer (prewarmed to 37°C), digested with MNase (50 units/ml) at
37°C for 5 minutes, and terminated by 5 mM EDTA. An
aliquot from each sample was assessed for sufficient chromatin fragmentation (500–1000bp) by gel electrophoresis. Samples were sonicated twice to ensure lysis of the
nuclei prior to immunoprecipitation. The remaining steps
of the immunoprecipitation were performed using the
EZ ChIP™ Chromatin Immunopreipitation Kit (Upstate)
per manufacturer’s instructions. Subsequently, anti-SRF
(Santa Cruz) or appropriate IgG control (Sigma Aldrich)
were added for immunoprecipitation. For each immunoprecipitation, 5 µg of the appropriate antibody was incubated with a precleared chromatin aliquot overnight at
4°C with rotation. The next day, protein A/G sepharose
beads were added and incubated for 1 hour at 4° with rotation. The immunoprecipitates were pelleted, washed and
the antibody-protein-DNA complex was eluted from bead
by incubation in 100 mM NaHCO3 and 1%SDS. Following
immunoprecipitation and elution, the eluent was treated
with RNase A followed by reverse crosslinking by incubation at 65°C overnight. Protein was removed by addition
of proteinase K and incubation at 45° for 2 hours. DNA
was purified using mini columns provided by kit manufacturer. Purified DNA was amplified by specific primers [13]
and PCR was performed under the following conditions: 1
cycle at 95° for 15 min, 40 cycles of 94° 1 min, 58° 1 min,
72° 1 min; and a final extension step at 72° for 5 minutes
followed by analysis of melting curve. Data was normalized to the signal detected from the input of each sample. The fold enrichment of each target site was calculated
as 2 to the power of the cycle threshold (cT) difference
between input chromatin and ChIP samples.

Western Analysis

Lysates were prepared and 100 mg were denatured and
electrophoresed through denaturing polyacrylamide gels
(10%) followed by electrophoretic transfer as previously
described. For assessment of phospho-SRF and phosphop38 relative to their cognate total protein levels, the same
lysate was run on separate gels due to the utilization of
a separate membrane blocking protocol for anti-phospho antibodies relative to the blocking protocol used for
all other antibodies. For the following antibodies, each
diluted 1:1000: from Santa Cruz; anti-SRF, from Cell Signalling; anti-p38, and from Abcam; anti-MyoD, membranes
were blocked for one hour in 1 × TBS/0.1%NP40 with
10% newborn calf serum and 5% dry milk. For the following antibodies, each diluted 1:1000: from Cell Signalling,
anti-phospho-p38 and anti-phospho-SRF, membranes were
blocked for one hour in 1 × TBS/0.1%NP40 with 5% BSA.
Western analysis using anti-actin (Sigma) or anti-hsp70 (BD
Biosciences) served as loading and transfer controls (each
diluted 1:30,000). All primary antibodies were incubated
overnight at 4°C. Appropriate HRP-conjugated secondary
antibodies, diluted 1:1000, were incubated with the membranes for one hour. After each incubation with antibody
and prior to the addition of chemiluminescent substrate,
membranes were washed five times in 1 × TBS (Tris- buffered saline pH 7.4) with 1% Tween 20. Membranes were
then incubated with (SuperSignal West Pico Chemiluminescent Substrate: Thermo Scientific: #34078) for 60 seconds
and bands were visualized using (Li-Cor Phospho-imager:
Image Studio Ver. 2.1). Note that multiple Western analysis were run from the same set of s amples to eliminate as
much variablity as possible.
Quantitative RT-PCR

Myoblasts were plated at equal density and the next day
cultured as indicated in the figure legend. For quantitative
RT-PCR, total RNA was prepared using 1 mL of Trizol (Invitrogen) reagent per 100 mm plate for lysis and following
the manufacturer’s instructions. Five hundred ng of RNA
was then used for a 20 µL SuperScript III RT (Invitrogen)
reverse transcription reaction. Quantitative PCR (qPCR)
was performed for MyoD as described [13] using a BioRad DNA Engine Opticon 3 Real-Time PCR System using
SYBR® Green Master PCR Mix according to the manufacturer’s instructions (Qiagen).
Results

Effects of dn-DR5 on signaling events regulating
MyoD expression

SRF is the transcription factor known to drive the expression of MyoD in GM by binding the CArG box in the serum
response element (SRE) of the distal regulatory region
(DRR) of the MyoD gene [14]. To investigate the effect of
dn-DR5 expression in skeletal myoblasts on the binding of
SRF to this CArG box, we utilized chromatin immunoprecipitation (ChIP) analysis. The binding of SRF to the CArG
box in the DRR of the MyoD gene in myoblasts expressing dn-DR5 was reduced by at least 70% when compared
to levels of binding in parental control 23A2 myoblasts
(Figure 1A). Specific phosphorylation of SRF is known to
enhance the ability of SRF to specifically bind DNA [15].
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These decreased levels of SRF bound to the CArG box as a
consequence of dn-DR5 expression are not a consequence
of an overall decrease in SRF levels, but rather correlate
with decreased levels of this specifically phosphorylated
SRF (Figure 1B and C).
Several reports indicate that p38 kinase plays a pivitol
role in regulating SRF phosphorylation and transcriptional activity [16–19]. We, therefore, utilized Western
analysis to investigate the effect of dn-DR5 expression on
the phosphorylation status of p38 indicative of activation
[17]. We determined that lysates prepared from myoblasts
expressing dn-DR5 possessed reduced levels of specifically
phosphorylated p38, without a corresponding decrease in
total p38, relative to lysates prepared from parental control myoblasts (Figure 2A and B).
Effects of caspase 3 inhibition on phosphorylation of
p38 and subsequent signaling events regulating MyoD
expression

Phosphorylation and activation of p38 kinase can occur in
response to a multitude of signaling events, including caspase 3 mediated cleavage of several upstream kinases [17].
We have previosuly reported that expression of dn-DR5
in skeletal myoblasts results in decreased basal caspase
3 activation [13]. As a second approach to confirm that
basal signaling from caspase 3 through p38 kinase results
in phosphorylated SRF and subsequent maintenance of
MyoD expression, we next treated parental myoblasts

Figure 1: dnDR5 expression decreases SRF binding to the
CArG box in the DRR of the MyoD enhancer as well as
specific phosphorylation of SRF. In (A) chromatin from
1 × 107 cells was cross-linked and digested with MNase
to a length between 500–1000 bp. Chromatin Immunoprecipitation was performed on each cell sample using EZ
ChIPTM Chromatin Immunoprecipitation Kit (Upstate)
per manufacturer’s instructions. Chromatin from 2 ×
106 cells was immunoprecipitated as described in Methods. Quantitative PCR was used to assay for the relative
levels of SRF binding near MyoD CArG element. Data was
normalized to the signal detected from the input of each
sample and presented as a percent of the signal obtained
from parental 23A2 myoblasts. Error bars represent mean
+/– SEM of triplicates. In (B) and (C), equal cell numbers
were plated and the next day lysates were prepared and
subjected to SDS-PAGE. Western analysis was performed
using anti-phospho SRF, anti-SRF or anti-β-actin (loading
and transfer control) and visualized as described in Methods. Shown are the results of one experiment that are representative of three independent experiments for (B) and
two independent experiments for (C).

Figure 2: dnDR5 expressing myoblasts possess decreased
levels of specifically phosphorylated p38. For each,
equal cell numbers were plated and the next day lysates
were prepared and subjected to SDS-PAGE. Western
analysis was performed using anti-phospho p38 (A),
anti-p38 (B), or anti-Hsp70 (loading and transfer control) and visualized as described in Methods. Shown are
the results of one experiment that are representative of
three independent experiments for (A) and two independent experiments for (B).
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with the caspase 3 inhibitor DEVD-fmk. Treatment of
parental myoblasts with DEVD-fmk for either 3 or 6 hours
resulted in decreased levels of specifically phosphorylated
p38 kinase (Figure 3A) without a corresponding decrease
in total p38 (Figure 3B). Moreover, treatment of parental
myoblasts with DEVD-fmk for either 3 or 6 hours resulted
in decreased levels of specifically phosphorylated SRF
(Figure 4A) without a corresponding decrease in total SRF
(Figure 4B). Finally, treatment of parental myoblasts with
DEVD-fmk resulted in decreased levels of MyoD protein
(Figure 5A), a corresponding decrease in MyoD mRNA
(Figure 5B) and SRF binding to the CArG box in the DRR
of the MyoD enhancer (Figure 5C). In each aspect measured, caspase 3 inhibition mimicked the effect of dn-DR5
expression.
Effects of p38 kinase inhibition on phosphorylation
of SRF and subsequent signaling events regulating
MyoD expression

and decreased levels of SRF binding to the CArG box in the
DRR of the MyoD enhancer (Figure 7C). In each aspect
measured, p38 inhibition mimicked the effect of dn-DR5
expression.
Direct confirmation that a decrease in the binding of
phosphorylated SRF to the DRR awaits, at a minimum,
the development of an anti-phospho SRF antibody that
can be utilized for ChIP analysis. Nonetheless, taken
together, these data still indicate that a decrease in
caspase 3 activity, such as that detected upon expression of dn-DR5 in skeletal myoblasts [13], is sufficient
to result in decreased phosphorylation and activation
of p38 kinase, decreased levels of phosphorylated SRF,
decreased binding of SRF to the CArG box in the DRR
of the MyoD enhancer and decreased levels of MyoD
expression (Figure 8/model).

Finally, we treated parental myoblast with the p38 inhibitor SB 203580. Lysates prepared from parental myoblasts
treated with SB 203580 for either 3 or 6 hours possessed decreased levels of phosphorylated SRF without a
decrease in total SRF (Figure 6A and B). This decreased
level of phosphorylated SRF induced by treatement with
SB 203580 correlated with a corresponding decrease in
MyoD protein and mRNA (Figure 7A and B, respectively)

Discussion
A thorough molecular understanding of the coordinate
regulation of differentiation and apoptosis is pre-requisite to the manipulation of these biologically distinct
endpoints as a therapeutic approach. For instance, manipulation of the apoptotic pathway, without affecting the differentiation pathway, requires identification of molecules
unique to the apoptotic pathway. To this end, we have previously reported that the DR5 pathway plays a critical role
in both the apoptosis and the differentiation of skeletal

Figure 3: Myoblasts treated with a caspase 3 inhibitor
possess decreased levels of specifically phosphorylated
p38. For each, equal cell numbers were plated and the
next day treated (or not) with DEVD-fmk as indicated in
Methods. After the the indicated times, lysates were prepared and subjected to SDS-PAGE. Western analysis was
performed anti-phospho p38 (A) or anti-p38 (B). Western analysis using anti-Hsp70 served as the loading and
transfer controls. Bands were visualized as described in
Methods. Shown are the results of one experiment that
are representative of three independent experiments
for (A) and two independent experiments for (B).

Figure 4: Myoblasts treated with a caspase 3 inhibitor
possess decreased levels of specifically phosphorylated
SRF. For each, equal cell numbers were plated and the
next day treated (or not) with DEVD-fmk as indicated in
Methods. After the the indicated times, lysates were prepared and subjected to SDS-PAGE. Western analysis was
performed anti-phospho pSRF (A) or anti-SRF (B). Western analysis using anti-Hsp70 served as the loading and
transfer controls. Bands were visualized as described in
Methods. Shown are the results of one experiment that
are representative of three independent experiments
for (A) and two independent experiments for (B).
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Figure 6: Myoblasts treated with a p38 inhibitor possess
decreased levels of specifically phosphorylated SRF.
For each, equal cell numbers were plated and the next
day treated (or not) with SB 203580 for the indicated
times. In (A) and (B), Western analysis was performed
using anti-phospho SRF or anti-SRF, respectively with
anti-actin serving as the loading and transfer control.
Bands were visualized as described in Methods. Shown
are the results of one experiment that are representative of three independent experiments for (A) and two
independent experiments for (B).

Figure 5: Myoblasts treated with a caspase 3 inhibitor
possess decreased levels of MyoD protein, mRNA and
SRF binding to the CArG box in the DRR of the MyoD
enhancer. For each, equal cell numbers were plated and
the next day treated (or not) with DEVD-fmk for the
indicated times. In (A) Western analysis was performed
using anti-MyoD or anti-Hsp70 (loading and transfer
control) and visualized as described in Methods. Shown
are the results of one experiment that are representative
of three independent experiments. In (B) quantitative
RT-PCR was used to assay for the relative levels of MyoD
mRNA in total RNA samples derived from the indicated
cell cultures. The Ct values for the MyoD PCR product
were normalized to the Ct values for a β-actin product,
run in parallel, as described in Methods. Error bars represent mean +/– SEM from triplicates. In (C), ChIP analysis
was perfomed as described in the Figure 1 legend.
myoblasts. In skeletal myoblasts, the DR5 proximal molecules responsible for executing both the differentiation
and the apoptotic pathways is caspase 8 signaling through
caspase 3. The distinction between signaling that allows
for differentiation and signaling that induces apoptosis

resides in the level of activation. Specifically, elevated signaling by DR5 in differentiation medium (DM) contributes
to the apoptosis that occurs in a subset of myoblasts [10],
while basal signaling from DR5/FADD/caspases in growth
medium (GM) is necessary to maintain the level of MyoD
expression and thus allow for the differentiation of the
majority of myoblasts when cultured in DM [13]. Recently,
the importance of widespread basal caspase signaling has
been reported in whole animal studies [20, 21].
A plethora of examples of non-apoptotic roles for apoptotic molecules have been reported. However, the vast
majorities of these examples are for Bcl2 family members
or caspases and rarely have the non-apoptotic signaling
events downstream of the apoptotic molecules been elucidated [22–24]. The DR5 pathway has been implicated in
the non-apoptotic role of inducing intestinal cell differentiation, but again the downstream signaling molecules
were not determined [25]. With respect to myogenesis, a
role for caspase-3 has been documented at several steps.
Firstly, caspase-3 activity is required to remove Pax7,
allowing myoblast stem cells to switch from self-renewal
to differentiation competence [26]. Secondly, after myoblasts have been switched from GM to DM, caspase-3
mediated CAD (caspase-activated DNase) activation plays
a role in the chromatin modification and subsequent
expression of p21, one of the key molecules required for
cell cycle exit [27]. Further, in DM, caspase-3 activation
has been linked to the subsequent activation of p38 [28].
Multiple roles for p38 signaling during skeletal myoblast
differentiation has also been well characterized [29].
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Figure 8: Model depicting the signalling pathway from
DR5 to SRF-mediated transcription of MyoD. Basal signaling from DR5 to capases 8 and 3 results in specifically
phosphorylated p38. Active p38 in turn leads to specifically phosphorylated SRF, SRF binding to the CArG box in
the DRR of the MyoD enhancer, and expression of MyoD.

Figure 7: Myoblasts treated with a p38 inhibitor possess
decreased levels of MyoD protein, mRNA and SRF binding to the CArG box in the DRR of the MyoD enhancer.
For each, equal cell numbers were plated and the next
day treated (or not) with SB 203580 for the indicated
times. In (A), Western analysis was performed using antiMyoD or anti-Hsp70 (loading and transfer control) and
visualized as described in Methods. Shown are the results
of one experiment that are representative of three independent experiments. In (B), quantitative RT-PCR was
used to assay for the relative levels of MyoD mRNA as
described in the legend to figure 5. In (C), ChIP analysis
was perfomed as described in the Figure 1 legend.
These elegant studies carefully documented the molecular effects of caspase-3 and p38 signaling that contribute to the differentiation process in skeletal myoblasts.
However, these studies did not address the mechanism(s)
responsible for caspase-3 activation. Moreover, these
studies were focused on signaling events that occur once
myoblasts were cultured in DM.

Our studies were focused on signaling that occurs in
GM. Herein, we idenitfy the molecules responsive to
basal DR5 signaling in GM that serve to maintain MyoD
expression and allow for subsequent differentiation in
DM. Specifically, we document that basal DR5/caspase
signaling in GM leads to constitutive phosphorylation and
activation of the p38 kinase which in turn phosphorylates
and activates SRF, driving the expression of MyoD. The
significance of SRF activity in driving MyoD expression in
skeletal myoblasts in both GM and DM has been well documented [14, 30]. In DM, SRF activity has been shown to
be regulated by RhoA [31]. Given that SRF is by definition
serum responsive via Ras pathway signaling to the ternary
complex factor (TCF) [32], further exploration of other
mechansims contributing to the activation of SRF in GM
has not been exhaustively addressed. Our data support
a model whereby basal DR5 signaling through caspasemediated activation of p38 plays a role in maintaining SRF
activation and subsequent MyoD expression in GM.
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